The crystal structure of FMDV A10(61) reveals that despite antigenic variation, the heparin receptor binding site is conserved, though with altered binding affinity.
No takes yet. Share an insight, caveat, or question.
Conserved FMDV receptor site across variants; leaves open whether this informs vaccine or host-range studies.
Elizabeth E. Fry (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: